PPARG and metabolic dysfunction-associated steatotic liver disease: For example, the hepatocyte-derived lncRNA (lnc-HC) regulates hepatic lipid droplets accumulation via the miR-130-3p/PPARγ pathway [138], implying that lnc-HC could be a potential therapeutic target to prevent excessive lipogenesis, lipid accumulation, and NAFLD phenotype.